Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx
โ Scribed by Ichiro Tateya; Shigeru Hirano; Hisayoshi Kojima; Koichi Omori; Kazuhiko Shoji; Michihide Mitsumori; Yasushi Nagata; Juichi Ito
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 198 KB
- Volume
- 263
- Category
- Article
- ISSN
- 0302-9530
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background Our aim was to evaluate the efficacy and toxicity of chemoradiotherapy (CRT) with transoral debulking microsurgery for T2N0 glottic cancer. ## Methods Thirty patients with T2N0 glottic cancer treated with concurrent hyperfractionated radiotherapy (RT) and carboplatin we
Between March 1978 and April 1986, 21 previously untreated patients with T3 squarnous cell carcinoma of the true vocal cord received radical courses of twice-a-day radiotherapy (1 20 cGy twice daily) to total doses of 7,440-7,680 cGy. The rate of local control at the primary site was 67% after radio
Background. This study was undertaken to analyze the clinical course of patients who developed local (primary) recurrence after high-dose irradiation of T1 -T2 squamous cell carcinoma of the glottic larynx. Methods. Between May 1977 and December 1989, 247 patients with previously untreated T1 and T